Population Pharmacokinetics of Semaglutide for Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-019-0581-y
Published Online: 2019-02-20
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Overgaard, Rune V.
Delff, Philip H.
Petri, Kristin C. C.
Anderson, Thomas W.
Flint, Anne
Ingwersen, Steen H.
Funding for this research was provided by:
Novo Nordisk A/S
Text and Data Mining valid from 2019-02-20
Version of Record valid from 2019-02-20
Article History
Received: 4 February 2019
First Online: 20 February 2019